One of the critical limitations of current microarray technologies for use in expression analyses is the relatively large amount of input RNA required to generate labelled cDNA populations for array analysis. In situations where RNA is limiting, the options for expression profiling are to increase cDNA labelling and hybridisation efficiency, or to use an amplification strategy to generate enough RNA/cDNA for use with a standard labelling method. Sample amplification approaches must preserve the representation of the relative abundances of the different RNAs within the starting population and must also be highly reproducible. This review evaluates current signal and sample amplification technologies, including those that can be used to generate labelled cDNA populations for array analysis from as little as a single cell.
INTRODUCTION
As microarrays have become a standard technology for measuring relative and absolute levels of gene expression, so interest in increasing the resolving power of this technology has grown, particularly in terms of the amount of input material required to generate robust data. 1, 2 The drive for these modifications is partly technical, but is also motivated by biological and clinical concerns. In both cases, the main goal is to use defined populations of cells or small pieces of complex tissues, such as a clinical biopsy, for expression profiling. Using such cell populations is likely to be associated with a reduction in the number of cells that can be harvested. Laser capture microdissection and similar technologies in clinical and research settings have made it possible to collect defined cells from fresh and fixed tissue sections. 3, 4 The ultimate aim of this increase in resolution is to enable reproducible expression profiling at the level of single cells. In this context, there have been several recent reports indicating that this is currently feasible and is likely to be in general use in the near future. [5] [6] [7] [8] [9] Current methods in general use for generating labelled cDNA populations for array analysis require microgram amounts of total RNA, or the equivalent of over 1 million cells (see www.microarrays.org for detailed protocols). Efforts to reduce this requirement have focused on two complementary approaches: signal amplification and detection, allowing the use of smaller amounts of input RNA; RNA sample amplification to generate enough material for standard labelled cDNA synthesis, hybridisation and detection; or a combination of both (see Figure 1 for summary).
SIGNAL VERSUS SAMPLE AMPLIFICATION: THEORY
Ideally, it would be possible to extract the RNA from a single cell, directly label that RNA and hybridise it to some form of microarray. There are many practical issues with such an ideal situation, however, ranging from the difficulties inherent in harvesting picogram quantities of RNA contained in a typical single mammalian cell through to the hybridisation kinetics for very small numbers of molecules at relatively low concentrations.
Tissue-based estimates from brain cDNA libraries indicate that there are three classes of mRNA abundance. 10 High abundance transcripts make up approximately one-sixth of the mass of mRNA in the central nervous system and represent 100 different transcripts; medium abundance transcripts make up over 45 per cent of the mass of mRNA, and represent 2,000 different transcripts; whereas the final 40 per cent is composed of low abundance transcripts representing 45,000 different transcripts. 10 Although it should be noted that these are estimates from a single, complex tissue, it is likely that values from other tissues will approximate these values.
There is an inherent technical challenge in labelling all of these low abundance transcripts for microarray hybridisation under any circumstances, and developing hybridisation conditions that would ensure that all molecules hybridise in a reasonable timeframe. Under conditions where the input RNA and the corresponding absolute numbers of each low abundance transcript are low, these problems become more acute, with less room for errors in each step of the generation of a labelled cDNA population. A final technical hurdle, discussed below, is the detection of the extremely small numbers of molecules harvested from single cells.
SIGNAL AMPLIFICATION
The two main methods for generating labelled cDNA populations for array analysis in current use are direct incorporation of fluorescent labelconjugated nucleotides and incorporation of modified nucleotides followed by dye coupling to those modified nucleotides. These methods are in widespread use, with commercial kits available from many vendors for both methods. These methods have been described extensively in the literature and online and will not be discussed in detail here, other than to note that the indirect, or amino-allyl, labelling method was introduced both for relative cost reasons and also to reduce biases in the incorporation rates of different fluorophore-labelled nucleotides (see, for example, www.microarrays.org).
A current area of much interest is in strategies that not only label cDNA populations for array analysis, but also amplify that label such that smaller numbers of hybridised molecules can be reproducibly detected and quantified. There are several technically distinct methods in use for signal amplification. Enzymatic amplification of the signal, based on methods originally developed for increasing the sensitivity of immunohistochemical detection, is becoming increasingly popular. The most common of these is tyramide signal amplification, which has been commercialised by several vendors (see, for example, the NEN Micromax system). The basis of this approach is that tagged nucleotides are incorporated into the labelled cDNA populations for array analysis, and these tags are then detected either by specific antibodies or proteins (for example, avidin-biotin recognition) which are themselves conjugated to horseradish peroxidase (HRP). HRP in turn catalyses breakdown of tyramidefluorophore conjugates, with local deposition of the fluorophore. This method has been assessed to reduce the amount of input RNA required by 10-100 fold and to generate reproducible, representative results. 11 An alternative approach is the use of dendrimers to increase the amount of label per nucleotide and thus per labelled cDNA molecule (www.genisphere.com). This technology depends, as its name suggests, on the binding of highly branched molecules (dendrimers) to each hybridised molecule, often with each dendrimer carrying several hundred fluorescent tags, thereby increasing signal by a corresponding amount. In practice, the commercial kits available recommend input amounts of RNA down to 0.5 ìg. While considerably lower than the recommended amounts for standard labelling protocols of 5-20 ìg, this is still a considerable amount of RNA. One consequence of the presence of these Signal amplification can reduce input RNA requirements large, branched molecules is that hybridisation takes far longer than with standard methods, and is typically of the order of several days.
There are several alternative detection methods recently made commercially available or under development. Traditional radio labelled cDNA populations for array analysis have been used to increase the sensitivity of detection of hybridised molecules, but require alternative scanners to those used for fluorescent cDNA detection. 12 There is a great deal of interest in the potential for quantum dot, or nanocrystal technologies, to improve the sensitivity of detection of hybridised cDNAs, but they are not currently in general use (for details of this technology, see www.qdots.com). A promising method under development for signal amplification is rolling circle amplification. The basis for this technology, invented in David Ward's laboratory at Yale University, 13 is the amplification of a target circular construct annealed to a target sequence found in all of the hybridised cDNA molecules. 14 Typically, this target sequence can be introduced in the primer used for reverse transcription of the cDNA population from the starting RNA. Assessment of the general usefulness of these approaches will become possible as they are more widely applied.
SAMPLE AMPLIFICATION
An alternative to signal amplification is amplification of the input RNA to generate enough material for a standard labelled cDNA synthesis. Two technical approaches to such amplifications are in general use: exponential or polymerase chain reaction (PCR)-based amplification, and linear amplification.
The classical linear amplification method, first described by Eberwine and colleagues as a method for single cell analysis, is antisense RNA synthesis from a population of double-stranded cDNA molecules, all carrying a standard recognition site for T7 RNA polymerase. 15 This is now a common method for both amplifying cDNA populations and also for generating labelled RNA populations for array hybridisation, as used in the Affymetrix system (www.affymetrix.com). One round of amplification varies from 100-1,000-fold and there are several patents filed -reporting alterations in, for example, the priming site sequencewhich claim to increase the amplification efficiency. With current methods, amplification of nanogram quantities of total RNA (the equivalent of 50-1,000 cells) requires two rounds of T7 linear amplification. 16, 17 One feature of the standard T7 amplification protocols in current use is the shortening of the 
Label amplified RNA/cDNA by standard techniques amplified transcripts, compared to their parent mRNA population, with the associated 39-bias in the amplified material. 15, 18 Aside from classical T7-based amplification, there are other linear isothermal methods in use or under development, predominantly in the commercial sector. Several are more complex versions of the basic amplification of dsDNA by T7-mediated RNA synthesis, with the inclusion of multiple RNA polymerase binding sites and optimisations of the length of RNA molecules generated by RNA polymerase. The purposes of these modifications are to increase the efficiency of amplification while avoiding the 39-bias inherent in the original method.
PCR-based methods all share a common conceptual background: the introduction of PCR-priming sites at either end of each reverse-transcribed cDNA molecule, followed by global amplification of the entire population of molecules. Each of these steps presents potential pitfalls for the successful, representative amplification of the entire RNA/cDNA population. Failure to introduce priming sites to the ends of every RNA/cDNA molecule in the starting population will introduce sampling into the amplification process with the under-representation and possible amplification of those molecules. This is in addition to any possible sampling during the oligo-dT primed reverse transcription steps. The most significant source of error during PCRbased amplification, however, is during the PCR step itself, when the exponential nature of the process amplifies any variations in the amplification efficiency of particular templates.
The most-used PCR-based strategy for amplifying picogram, or single cell, amounts of RNA generates priming sites at either end of each cDNA molecule by the simple procedure of adding a tail of many adenine residues to the 39 end of the cDNA using terminal transferase, following oligo-dT-mediated reverse transcription. 8, 19, 20 To normalise cDNA fragment length, this method makes use of a brief, 10-15 minute, reverse transcription reaction, such that the final amplified cDNA fragments range in size from 100-500 bp. The shortcoming of this approach is that the amplified cDNAs are extremely 39-biased, which is a potential problem for downstream analysis using, for example, oligonucleotide arrays.
A second PCR method in general use for amplifying limiting amounts of RNA is the SMART system developed by Clontech. 21 This approach depends on the strand-switching properties of reverse transcriptase to introduce unique priming sites at each end of the reversetranscribed, single-stranded cDNA, followed by PCR amplification of the entire population. This method has been successfully used for generating labelled cDNA populations for array analysis from limiting amounts of RNA, and has been shown to preserve the relative abundance of RNA molecules in the amplified population. 22 The practical advantages of PCR-based methods are the exponential, rapid amplification of the cDNA population, and their relative ease of use. These are short, relatively simple protocols that are particularly useful in medium-and highthroughput situations where many samples are to be studied. In contrast, linear amplification methods are relatively labour-intensive, requiring the synthesis and purification of double-stranded cDNA from the starting RNA, followed by at least one round of RNA synthesis and purification. Depending on the degree of amplification required, this RNA is, in turn, used to synthesise double-stranded cDNA, followed by a second round of RNA synthesis. A typical time taken to generate amplified RNA from picogram quantities of input total RNA is of the order of 3-5 days. In contrast, PCR-based protocols typically take less than 1 day for the entire procedure. The implications of these There are two complementary amplification technologies: PCR and linear practical differences, however, must be weighed against the performance of each method in terms of reproducibility, sampling and representation of the starting RNA/cDNA population in the final amplified product.
Amplified material can be labelled to generate labelled cDNA populations for array analysis in a number of different ways. RNA generated by linear amplification can be labelled using standard direct and indirect labelling methods, or with the signal amplification methods discussed above. Amplified cDNA can be labelled by random primermediated incorporation of either directly or indirectly labelled nucleotides, as has been carried out by the author and other workers. 22 
PUSHING THE SYSTEM: THE CHALLENGE OF SINGLE CELL EXPRESSION PROFILING
Even with current labelling technologies, generating enough cDNA from a single cell for a single microarray hybridisation requires around 10 6 -fold amplification of the mRNA content of that cell. The total degree of amplification depends on the cell type used, given the wide range of total RNA content in different cell types, estimated to range from as little as 1 pg to as much as 50 pg. Only 1-5 per cent of this mass of RNA is composed of mRNA, containing an estimated total of 100,000-300,000 molecules of mRNA. Given that standard cDNA labelling methods require 5-20 ìg of total RNA, amplifying 300,000 molecules of different abundances to generate this mass of material represents a considerable challenge.
The above discussion on the technical issues involved in amplifying any RNA population is equally relevant to this extreme situation. The particularly acute problems for amplifying single-cell material, however, are the efficiency of priming the initial reverse transcription and the efficiency of the subsequent steps to prepare the cDNA for amplification, be they the introduction of a second priming site for PCR amplification or production of dsDNA from the single stranded material. Failure of either step for a sub-population of the cDNA will result in the absence of detection of low abundance transcripts. Assuming that all amplification methods introduce some degree of error over the million-fold amplification procedure, it is likely that amplification from single cells is an inherently 'noisy' procedure. With current technology, and from published reports, 18, 23 it is likely that linear amplification methods require three rounds of cDNA synthesis and linear amplification to generate enough material for a single microarray hybridisation.
PROSPECTS
Aside from the increasing implementation of the array technologies outlined above, there are several complementary technologies under development to achieve similar aims. Massively-parallel sequencing technologies are under development at a number of centres (see, for examples, www.solexa.com and www.lynxgen.com), and these technologies have obvious applications for expression profiling. Serial analysis of gene expression (SAGE) has been in widespread use for some time 24 and has been optimised for as few as 100,000 cells. 25 One area of future interest will be in adapting these technologies for expression profiling from small amounts of input RNA, eventually at the single cell level.
